11 January 2021
Visiongain has published a new report on Pharma Leader Series: Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021: In-depth Analysis of Top 50 Pharma CMOs: Capabilities, Results, Competition and Sales Potentials.
The global pharmaceutical contract manufacturing market was valued at US$xx billion in 2020 and is projected to reach at a market value of US$xx billion by 2031.
Are you in the global race? Where do you stand in the cut throat global competition?
Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.
Bio/Pharmaceutical Manufacturers’ Move Toward Strategic Collaboration With Drug Delivery Technology Companies
Rising healthcare costs, patent cliffs, the highly competitive pharmaceutical market and the need to develop innovative therapies are pushing researchers and market players to search for alternative and new drug delivery technologies. The resulting advanced drug delivery industry is playing a major role in shaping the bio/pharmaceutical industry. Companies with proprietary drug delivery technologies are collaborating with drug manufacturers to apply their technologies to existing products to protect themselves from generic versions and to further develop new drugs. Both the licensing and strategic collaborative business models exist in the drug delivery industry.
Lack of Manufacturing and Packaging Capabilities are Seen as Opportunity by CMOs
Numerous small drug developing companies do not have their own manufacturing facilities and packaging capabilities, so they are dependent upon outsourcing providers for their manufacturing and packaging needs. Halozyme engaged third parties to manufacture bulk rHuPH20, PEGPH20 and Hylenex recombinant. The company has supply agreement
Companies Profiled in the Report
AbbVie Contract Manufacturing
Aurobindo Pharma Ltd.
Avid Bioservices Inc.
Baxter Biopharma Solutions
Becton Dickinson and Co
Catalent Pharma Solutions Inc.
Consort Medical plc
Divi's Laboratories Ltd
Dr reddy lab
Edwards Lifesciences Corp
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Gilead Sciences, Inc.
Inovio Pharmaceuticals Inc.
Koninklijke DSM N.V.(Royal DSM)
Merck & Co.
Moderna Biotechnology company
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Zhejiang Hisun Pharmaceutical
How this report will benefit you?
The 434-page report provides clear detailed insight into the pharmaceutical contract manufacturing market. Discover the global top 50 rankings, top business strategies adopted by the key players, product mapping, services provided, recent activities of the companies, key drivers and challenges affecting the market.
Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 434-page report you will receive 400+ tables and 300+ figures– all unavailable elsewhere.
Key questions answered by this report:
• Detailed analysis and ranking of top 50 pharma CMOs in the global market
• Current status of market competition, market strategy analysis, product mapping, recent activities
• What is the current size of the total global pharmaceutical contract manufacturing market?
• How much will this market be worth from 2021 to 2031?
• How is the pharmaceutical contract manufacturing market evolving?
• What is driving and restraining the pharmaceutical contract manufacturing market?
• Who are the most prominent companies, and what are their activities and outlooks?
• What are the main trends that will affect the pharmaceutical contract manufacturing market between 2021 and 2031?
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.
02 March 2021
Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.
26 February 2021
The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.
22 February 2021
The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.